THE LUNG RESTORER

Bronchogen

Grade AExcellent

Restore lung health and breathe easier

Also known as: AEDL peptide

Pulmonary Health
Bioregulator

Overview

Bronchogen is a short peptide (AEDL) from the Khavinson family designed to support respiratory health. It works by modifying gene expression in lung tissue, helping restore the epithelial lining, reduce inflammation, and improve surfactant production. It's studied for COPD, chronic bronchitis, and age-related lung decline.

Key Benefits & Mechanisms

Epigenetic Regulation

Binds DNA to modify gene expression in lung tissue

Anti-Inflammatory

Reduces pro-inflammatory cytokines (TNF-α, IL-6)

Epithelial Repair

Restores bronchial lining and mucosal barrier function

Surfactant Production

Enhances lung surfactant for better gas exchange

Dosing Guide

Dosage

750 mcg daily

Schedule

daily

Cycle

4 weeks on, 8 weeks off

Pro Tip

Take in the evening 1-2 hours after last meal; subcutaneous or oral administration

Safety Profile

A

Excellent Safety

Excellent

Well-tolerated bioregulator peptide with minimal side effects.

Works slowly through gene expression changes. Best for long-term respiratory support.

Possible Side Effects

Mild injection site reactions

What to Expect

Week 1-2

Gene expression changes begin in lung tissue

Week 2-3

Reduced inflammation and improved breathing comfort

Week 4

Improved lung function measurements

Respiratory improvements develop over weeks; best results with repeated cycles.

Who Is This For

People with COPD or chronic bronchitis
Smokers or former smokers
Those recovering from respiratory infections
Aging individuals with declining lung function
Anyone exposed to environmental pollutants

Research References

Related Peptides

Ready to Start Your Peptide Journey?

Track your protocols, get guided reconstitution, and access our vetted vendor network — all in one app.

Download The Peptide App